Nanobac enlists Lebanese distributor for Middle East CNP (calcifying nanoparticles) sales:
This article was originally published in Clinica
Nanobac Pharmaceuticals, the Tampa, Florida-based specialist in nanobacteria-based diagnostics, has appointed Diagnostic Products Corporation Lebanon (DPCL) as its exclusive product distributor for the Middle East region. DPCL will sell Nanobac's CE-marked tests for calcifying nanoparticles (CNPs) in 11 countries, including Lebanon, Saudi Arabia, Syria, Jordan, Iraq, Kuwait, Bahrain and Egypt. The distributor is not affiliated to the US IVD company DPC that is now part of Siemens Medical Solutions Diagnostics. CNPs form a calcium phosphate coating identical to harmful deposits found in diseases such as atherosclerosis, kidney stones, prostatitis, breast cancer and ovarian cancer.